Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
electroCore, Inc. stock logo
ECOR
electroCore
$7.24
+3.1%
$6.21
$3.83
$8.08
$43.43M0.9113,439 shs31,917 shs
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
$0.10
-47.4%
$0.10
$0.03
$0.56
$38.87M2.317,405 shs11,300 shs
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$0.32
+6.6%
$0.63
$0.22
$2.79
$3.57M1.13157,578 shs25,130 shs
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$1.95
$1.61
$2.69
$32.98M0.419,793 shs113,500 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$46.26
-1.2%
$42.59
$3.69
$53.82
$1.55B-1.51360,240 shs427,837 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
electroCore, Inc. stock logo
ECOR
electroCore
+0.29%+14.71%+16.61%-3.04%+16.03%
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
0.00%0.00%0.00%0.00%0.00%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-6.41%+6.75%-19.47%-73.74%-81.07%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.00%0.00%0.00%0.00%0.00%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
+1.87%+4.79%+11.96%+0.47%+1,014.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/AN/AN/AN/A
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/AN/AN/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.4315 of 5 stars
2.50.00.04.61.94.20.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
electroCore, Inc. stock logo
ECOR
electroCore
3.00
BuyN/AN/A
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.00
Buy$55.6020.19% Upside

Current Analyst Ratings

Latest NDRA, FCRE, PEYE, ECOR, and SLNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/14/2024
electroCore, Inc. stock logo
ECOR
electroCore
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 5/8/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
electroCore, Inc. stock logo
ECOR
electroCore
$16.03M2.71N/AN/A$1.24 per share5.84
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
$40K971.79N/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$0.67 per shareN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
$15.68M0.00N/AN/A$0.53 per share0.00
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.16 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
electroCore, Inc. stock logo
ECOR
electroCore
-$18.83M-$3.56N/AN/AN/A-117.49%-201.47%-109.61%5/8/2024 (Confirmed)
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
-$2.04MN/A0.00N/A-4,265.28%-24.94%-9.42%N/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$10.06M-$1.93N/AN/AN/A-197.36%-144.22%5/14/2024 (Confirmed)
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
-$930K-$0.06N/AN/AN/A-5.93%-12.10%-6.41%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$38.99M-$2.97N/AN/AN/AN/A-79.65%-52.92%5/14/2024 (Estimated)

Latest NDRA, FCRE, PEYE, ECOR, and SLNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2024N/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/AN/A
5/8/2024N/A
electroCore, Inc. stock logo
ECOR
electroCore
-$0.50N/A+$0.50N/AN/AN/A  
3/28/2024Q4 2023
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A-$0.17-$0.17-$0.17N/AN/A
3/13/2024Q4 2023
electroCore, Inc. stock logo
ECOR
electroCore
-$0.55-$0.61-$0.06-$0.61$5.23 million$5.19 million    
3/6/2024Q4 2023
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.31-$0.33-$0.02-$0.33N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.76
1.49
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/A
0.01
0.01
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
6.26
3.36
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
0.23
1.42
0.76
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/A
14.89
14.89

Ownership

Institutional Ownership

CompanyInstitutional Ownership
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%

Insider Ownership

CompanyInsider Ownership
electroCore, Inc. stock logo
ECOR
electroCore
13.14%
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
5.04%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
4.80%
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
22.70%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
28.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
electroCore, Inc. stock logo
ECOR
electroCore
686.00 million5.21 millionNot Optionable
Fc Global Realty Inc stock logo
FCRE
Fc Global Realty
N/A389.10 millionN/ANot Optionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
2111.04 million10.51 millionNot Optionable
Precision Optics Co., Inc. stock logo
PEYE
Precision Optics
5016.92 million13.08 millionNot Optionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3333.41 million23.79 millionOptionable

NDRA, FCRE, PEYE, ECOR, and SLNO Headlines

SourceHeadline
While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last weeks 4.8% gain, private equity firms stood to gain the mostWhile institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
finance.yahoo.com - May 8 at 11:07 AM
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Down to $49.23Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Down to $49.23
americanbankingnews.com - May 5 at 3:38 AM
Vivo Opportunity, Llc Sells 750,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) StockVivo Opportunity, Llc Sells 750,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stock
americanbankingnews.com - May 3 at 4:04 AM
Soleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hoursSoleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hours
nasdaq.com - May 3 at 1:48 AM
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockSoleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
globenewswire.com - May 2 at 10:32 PM
Soleno Therapeutics Announces Proposed Public Offering of Common StockSoleno Therapeutics Announces Proposed Public Offering of Common Stock
globenewswire.com - May 2 at 4:01 PM
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Vivo Opportunity, Llc Sells 750,000 SharesSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Vivo Opportunity, Llc Sells 750,000 Shares
insidertrades.com - May 2 at 5:48 AM
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeSoleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
globenewswire.com - April 30 at 8:00 AM
Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide CholineSoleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline
marketwatch.com - April 29 at 4:41 PM
Soleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide CholineSoleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide Choline
marketwatch.com - April 29 at 4:41 PM
Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To WatchSoleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watch
seekingalpha.com - April 29 at 4:41 PM
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89
marketbeat.com - April 29 at 12:11 PM
Why Soleno Therapeutics Stock Is Skyrocketing TodayWhy Soleno Therapeutics Stock Is Skyrocketing Today
fool.com - April 29 at 11:11 AM
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
globenewswire.com - April 29 at 8:00 AM
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 19 at 4:05 PM
Soleno Therapeutics (NASDAQ:SLNO) Shares Up 3.4%Soleno Therapeutics (NASDAQ:SLNO) Shares Up 3.4%
marketbeat.com - April 15 at 2:49 PM
Carlyle Group Inc. Acquires 564,242 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Carlyle Group Inc. Acquires 564,242 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)
marketbeat.com - April 14 at 8:45 PM
Soleno Therapeutics CEO sells over $780k in company stockSoleno Therapeutics CEO sells over $780k in company stock
investing.com - April 5 at 11:15 PM
Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,218 Shares of StockInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,218 Shares of Stock
insidertrades.com - April 4 at 6:49 AM
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
finance.yahoo.com - April 4 at 3:16 AM
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
finance.yahoo.com - April 4 at 3:16 AM
SLNO Apr 2024 40.000 putSLNO Apr 2024 40.000 put
finance.yahoo.com - March 16 at 10:33 PM
SLNO Apr 2024 35.000 putSLNO Apr 2024 35.000 put
finance.yahoo.com - March 16 at 7:31 AM
Construction of Solenos $22M pipe factory in Saratoga underwayConstruction of Soleno's $22M pipe factory in Saratoga underway
bizjournals.com - March 11 at 10:09 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

electroCore logo

electroCore

NASDAQ:ECOR
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Fc Global Realty logo

Fc Global Realty

OTCMKTS:FCRE
FC Global Realty Incorporated operates as a real estate investment company in the United States and internationally. It holds investments in various projects, such as high-end value hotels and resort communities; residential developments; and commercial properties, such as gas station sites. The company is based in Orangeburg, New York.
ENDRA Life Sciences logo

ENDRA Life Sciences

NASDAQ:NDRA
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Precision Optics logo

Precision Optics

OTCMKTS:PEYE
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Soleno Therapeutics logo

Soleno Therapeutics

NASDAQ:SLNO
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.